Ondansetron Hydrochloride News
Eurand Q4 Loss Widens On Higher Costs - RTT News
Eurand intends to discuss the further development of EUR-1025, the company's proprietary once-a-day oral formulation of ondansetron hydrochloride, ...
Eurand Reports Fourth Quarter and Year-end 2007 Key Achievements ... - Ad-Hoc-News (Pressemitteilung)
Ondansetron hydrochloride is marketed under the brand nameZofran(r) by GSK for the treatment and prevention ofchemotherapy-induced nausea and vomiting. ...
EURX: Positive Pharmacokinetic Study re Ondansetron vs GSK's Zofran(R) - Trading Markets (press release)
Ondansetron hydrochloride is marketed under the brand name Zofran(R) by GlaxoSmithKline for the treatment and prevention of chemotherapy-induced nausea and ...
Market Report -- In Play (EURX) - MSN Money
Ondansetron hydrochloride is marketed under the brand name Zofran by GlaxoSmithKline (GSK) for the treatment and prevention of chemotherapy-induced nausea ...
EURX: Positive Pharmacokinetic Study re Ondansetron vs GSK's Zofran(R) - Trading Markets (press release)
Ondansetron hydrochloride is marketed under the brand name Zofran(R) by GlaxoSmithKline for the treatment and prevention of chemotherapy-induced nausea and ...
Eurand Announces Positive Pharmacokinetic Study Results of Once-a ... - Primenewswire (press release)
Ondansetron hydrochloride is marketed under the brand name Zofran(r) by GlaxoSmithKline for the treatment and prevention of chemotherapy-induced nausea and ...
Beijing Med-Pharm Hopes To Grow Quickly Through Acquisitions - Seeking Alpha
Ondansetron. Ondansetron Flashtab , is a generic form of Zofran, a 5-HT(3) antagonist used to reduce nausea and vomiting induced by cytotoxic chemotherapy ...
Indian drug makers’ earnings in April-June to rise - Daily Times
It gained from sales of ondansetron hydrochloride tablets, a generic equivalent of GlaxoSmithKline Plc’s Zofran, used to prevent nausea and vomiting ...
Mylan Laboratories Q1 Profit Increases, EPS Declines; Revenues ... - Trading Markets
Last month, the company said that it secured final approval from the US Food and Drug Administration or FDA, for its Ondansetron Hydrochloride Tablets as ...
Glenmark gets USFDA nod to market cancer drugs - Economic Times
The company has received the approval for its Abbreviated New Drug Applications (ANDAs) Ondansetron Hydrochloride (HCI) in strengths of 4 mg, 8 mg, ...
Ondansetron Hydrochloride RSS Feed